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ABSTRACT
Dreams are experiences during sleep that are internally generated by the brain. Dreaming is a common phenomenon during 
normal sleep and may occur in all sleep stages. The brain is active during sleep, but perceptual connection to the environment 
is mostly turned off. However, the content of dreams can be affected by both external and internal stimuli. Dream recall is 
associated with higher frequency brain activity during sleep, typical of REM sleep and arousals. 
During parasomnias, dream experiences may be disturbed, behaviourally manifested or mixed with waking reality. 
Parasomnias are sleep disorders characterized by incomplete transitions between sleep and wake. Abnormal motor, sensory 
or behavioural manifestations of parasomnias occur at sleep onset, within sleep or during arousal from sleep. Various sensory 
stimuli may be able to disturb sleep causing arousals or partial awakenings typical of parasomnias. 
Differential diagnosis of parasomnias includes patient report of recalled and enacted dream content, timing and age 
at onset of parasomnia episodes, witnessed sleep behaviour, and polysomnographic findings about the sleep stage and 
the mechanism of episodes. In adults, parasomnias may have a significant negative effect on well-being and even violent 
consequences. A patient case with severe parasomnia overlap disorder and its treatment is presented.
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INTRODUCTION
Dreaming, as an altered state of consciousness, has 
interested and inspired creative and scientific approaches 
to understanding the human mind and existence since time 
immemorial. Dreaming is mostly beyond our control, though 
we spend a third of our life asleep, in the realm of dreams.  
Historically, psychoanalytic approaches in psychiatry 
have focused on dreams as the Freudian “Royal road to 
unconscious”, updating to working with dreams to explore 
dissociative disorders (1). Despite technological advances of 
neuroscience in modern psychiatry and established knowledge 
of sleep functions in general, scientific understanding of 
dreams is still rudimentary. 
Disturbing dreams are of clinical interest as they can be 
manifestations of mental distress, symptoms of psychiatric 
disorders, symptoms of sleep disorders, adverse effects 
of medications, outcomes of unhealthy behavioural and 
environmental factors or somatic illness. Parasomnias are 
common sleep disorders that can manifest with disturbing 
dreams, dream enactment and dream sensations during partial 
wakefulness. 
Parasomnias are characterized by abnormal motor, 
sensory or behavioural manifestations at sleep onset, within 
sleep or during arousal from sleep. They can disturb sleep 
quality and decrease daytime alertness. Parasomnias can 
cause secondary insomnia, marked psychological distress 
and harmful social consequences. Violent and disoriented 
behaviour may cause accidents.
Parasomnias can be elicited by various sensory inner (e.g. 
pain) or outside stimuli (e.g. noise), physiological, chemical, 
psychological and behavioural factors. Some known risk 
factors for parasomnias are sleep-disordered breathing, fever, 
heavy exercise, alcohol, anxiety and irregular sleeping times. 
Parasomnias are classified by the sleep stages into REM 
parasomnias (e.g. nightmares), and NREM parasomnias (e.g. 
sleep walking), with characteristic differences in timing, 
degree of recall, type of dream content, behavioural features 
and psychological stressors. 
Here, we review the phenomenology of dreaming 
and clinical features of the most important parasomnias, 
then present a special patient case presenting with severe 
overlapping parasomnia symptoms. The overlapping 
symptoms were challenging for differential diagnosis and 
treatment approaches for the lack of established guidelines. 
The relevance of psychiatric comorbidity and stressors were 
obvious in this case, but in particular, we hope that the case 
elicits interest in diagnosing and treating sleep disorders of 
psychiatric patients. 
The presented case is also an encouraging example of 
early treatment response to severe, injurious and debilitating 
parasomnia followed with a return to work despite a 
concomitant, trauma-related psychiatric disorder requiring 
further treatment. 
DREAMING 
Sleep is a resting state of the brain and body that typically 
consists of behavioural quiescence and unresponsiveness to 
sensory stimuli. However, unresponsiveness does not equal 
unconsciousness. Consciousness is commonly defined as the 
ability to have experiences, while unconsciousness is a state 
without any experiences whatsoever (2,3). 
During sleep, it is common for a sleeper to have subjective 
internally generated experiences which are disconnected 
from the environment. Static imagery and thoughts during 
sleep are called sleep mentation, and experiences involving 
sense of space and temporal progression are called dreams 
(4). However, during sleep-wake transitions and parasomnias 
this distinction between waking and dream consciousness can 
become blurred.
Dreaming is a common phenomenon during normal 
sleep. Although most of the dreams are not recalled, sleep 
laboratory studies suggest that people generally experience 
several dreams every night (5,6). There is no scientific 
consensus on why people dream. Nevertheless, several 
theories about dream function have been put forward. 
Emotional regulation theories propose that dreaming has 
a psychological function as emotionally loaded memories are 
processed during dreams, which is considered necessary for 
maintaining mental health (7). Though refined over the years, 
this line of thinking can be traced all the way to the work of 
Freud (8).
Random activation theories such as continuity hypothesis 
of dreaming claim that dreaming has no function of its own 
and is just a by-product of brain activation during sleep 
(9,10). Neurophysiological-focused variants of these theories 
started with identity theory that REM sleep is dreaming, when 
REM sleep stage was discovered (11), and modern variants 
propose that dreaming reflects memory consolidation and 
related neurological processes that happen during sleep, but 
has no function of its own (12,13).
Simulation theories of dreaming posit that it is possible 
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important for survival, including dangerous situations and 
important social interactions, and has been advantageous 
during evolution of the brain. Therefore, dreaming is an 
evolutionary adaptation and has a biological function (14,15). 
Variants of simulation theories include protoconsciousness 
theory, hypothesizing that simulating the world in dreams 
begins before birth and is necessary for brain development 
of a foetus (16).
Since dreaming consists of subjective experiences during 
sleep, studying it poses great challenges. There is no direct 
way of measuring or recoding experiences even though 
advances in brain imaging have identified several neural 
correlates of consciousness (17). Therefore, most information 
from dreams is based on retrospective dream reports given by 
the dreamer after waking up. This results in possible bias in 
related dream data due to unreliable recall and differences in 
reporting capability of individuals (18). 
Regardless of these methodological challenges, scientific 
dream research has advanced in recent decades after a long 
hiatus, and it has been demonstrated that dreaming has a 
robust connection with well-being. Dreams that are of special 
interest regarding mental well-being are nightmares. In ICD-
10, nightmares are defined as dream experiences loaded with 
anxiety and fear that are well remembered after awakening 
and some themes often reoccur from nightmare to nightmare 
(19). This sort of nightmare generally occurs during REM 
sleep stage though it is also possible to experience nightmarish 
imagery in NREM sleep.
Nightmares can be divided into idiopathic and post-
traumatic varieties. Idiopathic nightmares have content that is 
not clearly linked to actual events experienced by the dreamer. 
They are relatively common, with around half of adults 
experiencing at least one nightmare per month and 3-5% 
suffering from frequent nightmares (20,21). While occasional 
nightmares are harmless, frequent nightmares can pose a 
significant clinical problem if they cause daytime distress and 
disturb sleep. Frequent nightmares are often associated with 
symptoms of depression and insomnia as well as stress and 
life dissatisfaction (22,23).
Most common themes in nightmares are those related to 
physical attack or a threat of such an attack, social conflicts, 
being chased and falling (24,25). However, more important 
than the actual content are emotions that are evoked by these 
dreams. Dreams can include violent or dangerous situations, 
but if the emotional tone is neutral or positive these dreams 
are not nightmares. On the other hand, there are nightmares 
in which nothing objectively threatening happens, but which 
evoke a strong negative reaction for the dreamer.
Post-traumatic nightmares contain clear references to, 
or even replications of, traumatic events that the dreamer 
has experienced in their life. These kinds of nightmares 
are a normal reaction to a traumatic event and most people 
experience some nightmares related to such an event in the 
following weeks after trauma. Typically dreams about trauma 
become less frequent with time and disappear on their own, 
but in some cases they may become a chronic problem. 
In a study of veterans of the Second World War in Finland, 
increased frequency of nightmares among war veterans was 
observed over 30 years after the war had ended (21). Post-
traumatic nightmares are also one of the key symptoms of full 
post-traumatic stress disorder that also includes heightened 
arousal, depressive symptoms and avoidance behaviour, and 
can be a long-term mental health problem (26).
NEUROPHYSIOLOGY OF DREAMING
Most of human adult sleep consists of NREM (non-REM, or 
basic sleep including doze, light sleep and deep sleep) and, 
to a lesser extent, REM (rapid eye movement or paradoxical) 
sleep (20-25%) (27). Normal adult sleep architecture consists 
of five sleep cycles, each of which starts in healthy people 
with NREM sleep, deepening gradually and ending with 
lightened sleep and transitioning into REM sleep. There may 
be awakenings at the end of the cycles. The first cycles of the 
night normally contain deep N3 sleep (slow wave sleep) that 
diminishes towards the end of the night, whereas the REM 
sleep increases towards the end of the night. 
Dreaming may occur in all sleep stages, though the recall 
of dream content is more frequent and vivid for REM than 
NREM sleep. When awakening from REM sleep, the dream 
content is recalled 74-82% of the time (5,6,28). The REM 
dreams typically contain vivid sensory experiences and 
may have long and narrative content. Some of the rapid eye 
movement, characteristic of REM sleep stage, correspond 
to dream content related to gaze shifts within the dream, but 
some do not. Recall rate of NREM dreams is somewhat lower 
than for REM dreams, only 17-43%. NREM dream content is 
typically less narrative and consists of static scenes that the 
dreamer passively perceives. (5,6,28).
During REM sleep, there are shared neurophysiological 
phenomena with wakefulness. Some excitatory, glutamatergic 
brain stem neural circuits, dopaminergic limbic and 
motivational areas, and cholinergic projections from basal 
forebrain to cortex are active during REM sleep, but not during 
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contributes to active dream mentation, lower threshold of 
arousal and higher rate of dream recall (29,30).
Recall of sleep content is associated with local fast 
frequency, wake-like EEG activity. Gamma power (40Hz) 
increases the probability of dream recall at any sleep 
stage. Frontal activation is associated with more realistic 
dream content, as well as with conscious-like thinking in 
sleep, which relates to precise recall of dream content and 
misinterpretation of the stage as awake. Posterior activation 
is associated with more dreamlike, unrealistic content. The 
smaller size of delta waves during NREM sleep is associated 
with experience of dreaming and dream recall (5,6,31).
Special cases of dreaming with atypically active frontal 
activation are lucid dreams. They are typically REM dreams, 
but they may also occur at sleep onset when REM sleep is 
rare. In lucid dreams the sleeper becomes aware that he or 
she is dreaming and can sometimes control the dream scenery 
or guide the dream narrative (28). Recurrent, weekly lucid 
dreaming is quite rare (1%), but one half of the population has 
experience of lucid dreaming. Gamma power in prefrontal 
cortex is increased compared to non-lucid dreaming brain 
activity (32). 
During REM sleep muscle atonia, mediated by medulla 
glycinergic and GABAergic regulation, paralyzes striated 
muscles in the body. This prevents movement corresponding 
to motor cortex activation in REM sleep and behavioural 
dream content. Failure in muscle atonia, in combination 
with aggressive dream content, may lead to violent dream 
enactment, behaviour that is typical to certain parasomnias. 
There is no muscle atonia during NREM sleep stage, and that 
is why sleepwalking is possible during NREM deep sleep 
with partial awakening. During sleepwalking, eyes opened, 
the sleeper perceives the environment enough to move 
somewhat purposefully, but without wakeful consciousness. 
The interpretation of the environment is dreamlike. (33,34).
CLASSIFICATION OF PARASOMNIAS
NREM PARASOMNIAS
NREM parasomnias (Disorders of Arousal, DOA) are 
motor behaviours that arise from slow wave sleep during 
the sleep stage N3. The mechanism is incomplete transition 
to wake from N3. NREM parasomnias comprise a variety 
of manifestations with an increasing complexity from 
confusional arousal to sleep terror to sleepwalking. 
Between them, on the continuum of motor behaviour is 
sleep terror, also known as pavor nocturnus. Sleep terrors 
are characterized by extreme fear, motor agitation, intense 
vocalization and high autonomous activity (35). 
NREM parasomnias manifesting as partial arousals are 
sleepwalking (2-4% of adults), sleep terrors (1-2% of adults) 
and confusional arousals (3-15% of adults) (34,36). Variants 
of sleep walking, such as sleep-related eating disorder and 
sexsomnia, are also classified as NREM parasomnias. Subjects 
with NREM parasomnias often have comorbid anxiety and 
mood disorders, but the prevalence of sleep apnoea is also 
elevated (34). 
Unlike common expectation, most adults with sleep 
terror or sleepwalking occasionally remember the dream 
content. The dreams are typically short, visual and unpleasant 
with themes of danger, threat or catastrophe (37). Dreamlike 
mentation most often (95%) consists of a single visual scene. 
The patients with dream mentation reported more severe 
daytime sleepiness after NREM parasomnia episodes (38).
Onset age is typically in early childhood and they are 
common phenomena among children, often relieved by 
puberty. They may, however, persist or relapse in adulthood 
more often than reported in epidemiological studies (39). 
While major psychiatric problems are not common among 
these patients, elevated rates of parasomnias are reported 
among individuals with psychiatric disorders (40). 
Further, NREM parasomnias are triggered by factors 
increasing sleep fragmentation, such as psychosocial stress 
and anxiety in vulnerable individuals (41). Also, factors 
leading to increase of N3 sleep, such as sleep deprivation, 
night shifts or fever, predispose to disease episodes 
(41). Benzodiazepine receptor agonists and modulators, 
antidepressants, antipsychotics and beta-blockers are 
possible triggers for sleepwalking. The strongest evidence for 
medication-induced sleepwalking is for zolpidem and sodium 
oxybate (42).
REM PARASOMNIAS
REM parasomnias arise from REM sleep. 
Nightmare disorder includes recurrent, extended, extremely 
dysphoric, intensive and well-recalled dreams that lead 
to awakening, and becoming rapidly oriented and alert on 
awakening. They cause significant distress or impairment 
by the unpleasant dream, or by disruption of the sleep, and 
sometimes by secondary insomnia. Nightmare disorder is 
more common in children than adults (4%). It is often related 
to psychological stressors, and nightmares are common 





At population level, nightmares relate to symptoms 
of insomnia, alcohol use, a core symptom of depression 
and negative attitude towards self (Sandman 2015). 
Various substances affecting glutamatergic, noradrenergic, 
dopaminergic, GABAergic, histaminergic or cholinergic 
neurons may disturb dreaming by causing nightmares (43). 
Many antihypertensive, antidepressant and dopaminergic 
drugs can induce nightmares (37). 
Sleep paralysis is an incomplete transitioning from REM 
sleep to wake, so that the muscle atonia typical of REM 
persists while there is an intrusion of alpha activity (8-12Hz 
EEG) and consciousness during an otherwise desynchronized 
EEG. Sleep paralysis may be accompanied by a sensation of 
pressure on the chest and sometimes frightening hypnopompic 
hallucinations. Typical onset is in adolescence or young 
adulthood. Sleep paralysis is common in patients with 
narcolepsy, but occurs quite frequently (6%) as an isolated 
phenomenon in an otherwise healthy population (44).
REM sleep behaviour disorder (RBD) is a potentially 
violent and harmful motor enactment of dreams that is 
characterized by loss of muscle atonia during REM sleep. 
The behaviour occurs more towards the morning hours 
when REM sleep is more frequent (45). Patients with RBD 
often have violent dream content (46). Onset is typically in 
older age, often related to degenerative neural processes or 
medication. Earlier onset, from childhood to young adult, is 
typical of narcolepsy (33). 
RBD is often related to synucleinopathies, such as 
Parkinson’s disease, Lewy body dementia and multiple 
system atrophy, and it is usually an early sign of these 
diseases. However, RBD is also encountered in other 
neurodegenerative diseases, including Alzheimer’s disease, 
Huntington’s disease and amyotrophic lateral sclerosis (45). 
Other parasomnias like catathrenia (sleep-related 
expiratory groaning), exploding head syndrome (a sudden, 
non-painful sensation of explosion) and nocturnal enuresis 
(recurrent involuntary voiding during sleep) may occur at any 
sleep stage. Hypnagogic (at sleep onset) and hypnopompic 
(at waking) hallucinations occur during transitions between 
sleep and wake as isolated phenomena, or along with sleep 
paralysis, or as a part of narcoleptic tetrad.
TREATMENT OF NREM AND REM PARASOMNIAS
Treatment of parasomnias is indicated if the symptoms cause 
considerable distress, worry, social disturbance or severely 
disrupt sleep leading to daytime tiredness. Treatment 
is also needed if they threaten the safety of the sleeper or 
sleeping partner. There is, however, a lack of randomized 
controlled trials on the efficacy of pharmacological or non-
pharmacological intervention in parasomnias, with the 
exception of nightmares (47) and REM Behaviour Disorder 
(RBD) (48). 
For all parasomnias, treatment is based on identification 
and elimination of factors triggering the symptoms, such as 
irregular sleep-wake schedule, drugs or other sleep disorders, 
as well as maintaining a safe environment for prevention of 
sleep-related injury.
TREATMENT OF NREM PARASOMNIAS
Since NREM parasomnias share the same pathophysiological 
mechanism, the typical treatments overlap for certain 
priorities according to clinical picture. There are no 
established treatment guidelines for NREM parasomnias 
(49). Possible underlying predisposing factors, such as 
sleep apnoea and periodic limb movement disorder, should 
be excluded or treated. Predisposing medication should be 
discontinued (42).  
NREM parasomnias are usually benign, and in most 
cases there is no need for pharmacological therapy. Non-
pharmacological interventions include environmental safety, 
patient education and reassurance of benign prognosis, sleep 
hygiene, avoiding sleep deprivation, scheduled awakening, 
relaxation, stress management, hypnosis and psychotherapy. 
Pharmacological treatment is indicated if episodes of 
parasomnia are frequent and non-pharmacological methods 
are not sufficient. 
In NREM parasomnias, traditional pharmacological 
interventions aim to reduce deep N3 sleep and increase frontal 
inhibition without affecting too much REM sleep, if possible. 
Presently, the most commonly used drugs are GABA agonists 
such as benzodiazepines (e.g. clonazepam) or gabapentin. 
The authors also have preliminary positive experience with 
another gabapentinoid drug, pregabalin. Anti-epileptic drugs 
(e.g. topiramate, carbamazepine and sodium valproate), as 
well as antidepressants, such as tricyclic antidepressants, 
paroxetine and trazodone have been tried (34,49,50). No 
randomized clinical trials exist for any drugs.
TREATMENT OF REM PARASOMNIAS
As REM parasomnias have distinct mechanisms, the 
treatments are also different for each disorder. Also, in 
cases of REM parasomnias, the predisposing organic sleep 
disorders, brain diseases or toxic and pharmacological agents 
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should first be excluded. As RBD often precedes or presents 
with synucleinopathies in older age, a thorough neurological 
examination is necessary. 
Idiopathic nightmare disorder and nightmares induced 
by psychological trauma are most effectively treated by image 
rehearsal therapy (IRT) (37,51). Other non-pharmacological 
interventions, with lower evidence include systematic 
desensitization, progressive deep muscle relaxation training, 
lucid dreaming therapy and self-exposure therapy. 
Among pharmacological treatments, best evidence is 
for prazosin, a centrally active alpha-1 adrenergic antagonist 
(47). Lower grade evidence for medications are, for example, 
alpha-2 adrenergic agonist clonidine, antidepressants (e.g. 
trazodone, mirtazapine, tricyclic antidepressants), atypical 
antipsychotics (risperidone, quetiapine), gabapentin and 
certain long-acting benzodiazepines (37). 
Sleep paralysis does not generally need any treatment 
except explanation and reassurance, and there is no 
evidence-based treatment. Sometimes sleep paralysis is 
such a frightening experience for the patient that it leads to 
secondary insomnia and anxiety at bedtime. Antidepressants 
have sometimes been used with possible benefits by reducing 
the REM muscle atonia (44). Secondary insomnia and anxiety 
can often be managed with non-pharmacological methods. 
Resolving sleep paralysis may be hastened by consciously 
focusing on an outer stimulus, like watching a clock and 
hearing its sound. 
Treatment of RBD is closely linked to treatment of 
underlying neurological pathology. The safety measures and 
securing the sleeping environment are essential in management 
of RBD. Abrupt cessation of SSRIs and other antidepressants 
must be avoided, however, as they may provoke RBD attacks 
by increasing REM sleep as a rebound phenomenon. Possible 
pharmacological treatments, such as long-acting melatonin 
and clonazepam, may relieve symptoms (49,50). Melatonin 
has fewer adverse effects and it is more effective for elderly 
patients (44).
A PATIENT CASE WITH PARASOMNIA OVERLAP 
DISORDER 
Here we present a young NREM parasomnia patient, who 
presented with comorbid RBD symptoms. RBD is extremely 
rare in young people without predisposing neurological or 
pharmaceutical factors and in the absence of narcolepsy. 
A healthcare employee started to re-experience frequent, 
disturbing somnambulism and sleep terrors after moving 
back temporarily to his parents three years ago, at age of 26 
years. The episodes were more disturbing and frequent than 
in his childhood. New types of violent behaviour emerged. 
The sleep of the patient was severely fragmented by recurrent 
parasomnias as he had 2-10 attacks per night.   
When the violent parasomnia episodes emerged 3 years 
ago, he attacked his father while having a nightmare about 
an imaginary enemy. He sometimes broke pieces of furniture 
and rushed outside of the house. He could, for example, lift 
his bed against the door to protect himself, and carry his 
girlfriend out of the room to save her. He was also verbally 
aggressive during parasomnia episodes. Once he grabbed 
his girlfriend saying in English, “I kill you”, speaking to an 
imaginary dream enemy. Sometimes he was roaring like a 
bear, trying to scare away dream creatures. 
No serious accidents took place, but the patient was 
overwhelmed, frightened and worried about his parasomnia 
symptoms. Furthermore, he developed secondary insomnia 
because he was afraid of his potentially dangerous and socially 
undesirable sleep attacks. He was exhausted and sleepy, and 
had problems with memory and concentration. He had been 
on sick leave for 6 months before coming to psychiatric sleep 
disorder consultation. 
Before that, during the sick leave, a complete neurological 
examination, including brain magnetic resonance imaging, 
polysomnography and laboratory screen, was performed. 
There was no drug abuse and laboratory screenings were 
normal. During neurological examination, the patient had a 
2-month treatment trial with clonazepam with no response, 
only sedative and cognitive adverse effects. Self-medication 
with melatonin yielded no response either.
In psychiatric examination and sleep consultation he 
was diagnosed with post-traumatic stress disorder. In a few 
of his nightmares he re-experienced traumatic events from 
his childhood. His father’s behaviour had been uncontrolled 
and aggressive while he was drunk, and he had attacked the 
patient several times when he was a pre-teenager. Once his 
life was in danger when his father strangled him. He had put 
aside those memories, but they re-emerged in his dreams 
and his arousal threshold was very low.  Even minor outside 
stimuli could trigger incomplete awakenings and violent 
parasomnia attacks. He had been watchful and alert during 
day and night since his childhood, getting so used to it that he 
did not automatically consider it abnormal. 
Typical of NREM parasomnia, he was confused if woken 
up, had sleep inertia and sometimes sleep drunkenness with 
difficulty in waking up. He did not remember all the episodes, 
and the degree of dream recall varied. The timing, however, 
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was atypical for NREM parasomnia, as the episodes were 
occurring several times throughout the night, clustering 
around the early morning hours. Simultaneous nightmares 
and aggressive behaviour, corresponding to threatening and 
violent dream content, were also features referring to REM 
parasomnia rather than NREM parasomnia. He dreamed 
of escaping, fi ghting and defending himself against unreal 
enemies.
Polysomnography (PSG) with video recording was 
performed in sleep lab. Sleep apnoea and periodic limb 
movement disorder, as possible additional triggers for 
parasomnias, were excluded. PSG fi ndings, such as RSWA 
(REM sleep without atonia) and repeated transitions from 
N3 sleep to wake with simultaneous motor behaviour, 
correlated with physiological mechanisms of REM as well 
as NREM parasomnia. However, no characteristic diagnostic 
behavioural manifestations (somnambulism and sleep 
terrors) were seen in the video in the sleep lab. It is typical of 
laboratory recordings that the full symptomatology does not 
emerge as it does at home.  
The PSG recording showed 6 direct, abrupt transitions 
from deep N3 sleep to motor behaviour followed by waking 
EEG activity, characteristic of NREM parasomnia (Figure 
1-2). Behavioural manifestations of these confusional 
arousals were crying, climbing up to sit on the bed, turning 
on the lights and grabbing the PSG equipment. PSG also 
revealed an elevated chin muscle tone and some irregular limb 
movements during REM sleep (Figure 3-4), manifestations of 
RSWA (REM sleep without atonia), a feature of RBD (REM 
sleep behaviour disorder), but no destructive behaviour was 
demonstrated in the sleep lab. 
A new treatment approach had to be considered since 
the traditional treatment options had been proven to have a 
poor response. Clonazepam, with effi cacy for both NREM 
and REM parasomnias, had shown no response, only adverse 
cognitive effects, malaise and increasing tiredness. Melatonin, 
a typical treatment option for RBD and sometimes used in 
somnambulism, had yielded no response, nor adverse effects. 
Scheduled awakening was out of the question, because there 
was no fi xed time for episodes and they repeated several 
times a night. 
A low-dose doxepin trial (5mg) was started while the 
patient was in the queue for the sleep nurse. Doxepin was 
intended to treat secondary insomnia and to stabilize sleep 
by increasing the arousal threshold. With doxepin, there was 
a risk of NREM parasomnia escalation by increasing the 
amount of deep sleep, and a risk of RSWA progression by 
possible increase of muscle tone during REM, at least with 
higher doses. The initial response to doxepin during the fi rst 
two weeks was good, and the sleep was further stabilized by 
increasing the dose up to 7.5mg. Parasomnia episodes became 
milder and less frequent.  
Psychoeducation, reassurance, behavioural guidance (risk 
minimization, optimal sleep timing, relaxation) and cognitive 
methods (stress and anxiety management, image rehearsal) 
were offered by a sleep nurse. The risks to the patient and 
his bed partner were addressed by counselling and education, 
avoiding violent consequences by sleeping apart, removing 
potentially injurious objects, providing soft obstacles to 
stop rushing around, locking the doors, etc. Image rehearsal 
therapy is an evidence-based treatment for nightmare disorder 
(51) in which the patient modifi es the recurrent nightmare 
narrative into a more tolerable form, as well as working with 
the related self-attributions and emotions. 
Finally, the patient reported a remarkable relief of 
symptoms after 2 months of treatment. Parasomnia episodes 
did not recede, but instead of several times a night they 
occurred now every second night and they were milder. 
Severe, violent attacks were remarkably reduced (2 times in 2 
months) compared to previously (several times a night). The 
daytime tiredness receded and both physical and cognitive 
performance was so improved that the patient returned to 
work and his sport hobbies, enjoying them again.
Tuisku et al. Dreaming and parasomnias – A case with severe parasomnia overlap 




Figure 1. The first transition from N3 to wake, 17 minutes after falling asleep. Focus on 30 
seconds between epochs. There is some fast alpha activity running on the delta waves just 
before waking. Movement artifact on EEG and an elevated chin muscle tone, and marked 
increase in pulse are shown upon waking.  
Figure 2. The second transition from N3 to wake, 50 minutes after falling asleep. A full 30-
second epoch. There is some mild hypersynchronous delta waves before waking, and an 
autonomous arousal characterized by elevation of pulse.  
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Figure 2. The second transition from N3 to wake, 50 minutes after falling asleep. A full 30-
second epoch. There is some mild hypersynchronous delta waves before waking, and an 
autonomous arousal characterized by elevation of pulse.  
Figure 2. The second transition from N3 to wake, 50 minutes after falling asleep. A full 30-second 
epoch. There is some mild hypersynchronous delta waves before waking, and an autonomous arousal 
characterized by elevation of pulse. 
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Figure 3. The second REM phase at midsleep. Mild RSWA is seen in the 30-second epoch. Chin 
muscle (EMG) tone is slightly elevated with frequent small twitches. There are simultaneous 
facial and limb movements detected on video, not presented here.  
Figure 4. The third REM phase with a more pronounced RSWA seen in the 30-second epoch as 
an elevated chin EMG tone (two lowest derivations).  
7. Discussion 
Here we present a parasomnia patient who suffered from violent enactment of nightmares 
clustering in the early morning hours, consistent with REM sleep behaviour disorder. However, 
his young age was atypical of RBD in the absence of predisposing neurological disease or 
drugs. He responded well to low-dose doxepin, which was somewhat unexpected for RBD, as 
in small doses it does not decrease REM sleep as much as other, more commonly used 
antidepressant medications.  
However, in favour of a predominant NREM sleep disorder, our patient had a childhood history 
of NREM parasomnias (sleep terrors, somnambulism), and typical of NREM parasomnia he was 
often confused if woken up, with frequent amnesia of sleep attacks and often only vague 
dream recall. The video-PSG findings showed signs of both REM and NREM parasomnias: the 
partial lack of muscle atonia during REM, and transitions from deep sleep to wake, both with 
motor behaviour.   
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Figure 3. The second REM phase at midsleep. Mild RSWA is seen in the 30-second epoch. Chin 
muscle (EMG) tone is slightly elevated with frequent small twitches. There are simultaneous 
facial and limb movements detected on video, not presented here.  
Figure 4. The third REM phase with a more pronounced RSWA seen in the 30-second epoch as 
an elevated chin EMG tone (two lowest derivations).  
7. Discussion 
Here we present a parasomnia patient who suffered from violent enactment of nightmares 
clustering in the early morning hours, consistent with REM sleep behaviour disorder. However, 
his young age was atypical of RBD in the absence of predisposing neurological disease or 
drugs. He responded well to low-dose doxepin, which was somewhat unexpected for RBD, as 
in small doses it does not decrease REM sleep as much as other, more commonly used 
antidepressant medications.  
However, in favour of a predominant NREM sleep disorder, our patient had a childhood history 
of NREM parasomnias (sleep terrors, somnambulism), and typical of NREM parasomnia he was 
often confused if woken up, with frequent amnesia of sleep attacks and often only vague 
dream recall. The video-PSG findings showed signs of both REM and NREM parasomnias: the 
partial lack of muscle atonia during REM, and transitions from deep sleep to wake, both with 
motor behaviour.   
Figure 4. The third REM phase with a more pronounced RSWA seen in the 30-second 
epoch as an elevated chin EMG tone (two lowest derivations).
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Here we present a parasomnia patient who suffered from 
violent enactment of nightmares clustering in the early 
morning hours, consistent with REM sleep behaviour 
disorder. However, his young age was atypical of RBD 
in the absence of predisposing neurological disease or 
drugs. He responded well to low-dose doxepin, which was 
somewhat unexpected for RBD, as in small doses it does not 
decrease REM sleep as much as other, more commonly used 
antidepressant medications. 
However, in favour of a predominant NREM sleep 
disorder, our patient had a childhood history of NREM 
parasomnias (sleep terrors, somnambulism), and typical of 
NREM parasomnia he was often confused if woken up, with 
frequent amnesia of sleep attacks and often only vague dream 
recall. The video-PSG fi ndings showed signs of both REM 
and NREM parasomnias: the partial lack of muscle atonia 
during REM, and transitions from deep sleep to wake, both 
with motor behaviour.  
For the lack of a more accurate sleep disorder diagnosis, 
we diagnosed the patient with parasomnia overlap disorder, 
POD. In ICSD-3, POD is classifi ed as a subtype of RBD 
occurring with NREM parasomnias. However, considering 
the predominant NREM parasomnia symptoms, younger age 
of onset and lack of underlying neurological disease, POD 
most likely is a distinct entity instead of an RBD subtype 
(52). An updated classifi cation of POD also comprises RBD 
sleep-related eating disorder, RBD sexsomnia, RBD rhythmic 
movement disorder and POD with neurological disorders 
(53), further blurring the clear phenomenological distinction 
between NREM and REM parasomnias. 
Two-thirds of PODs are idiopathic whereas a third 
are related to neurological morbidity, especially alpha-
synucleinopathies (54). Though the pathophysiology of 
POD is unknown, it is possible that in some cases there is 
an evolution of sleep-related motor dyscontrol by ageing, 
with a more prominent DOA component earlier in life and 
RBD becoming more prominent during later years (52). RBD 
symptoms in patients under 50 years are often associated 
with narcolepsy (33). Other pathologies linked to POD are 
multiple sclerosis, brainstem structural anomalies or lesions, 
head trauma, ethanol abuse and post-traumatic stress disorder 
(PTSD) (54). 
Despite the association between POD and PTSD, 
there is no such association between psychological trauma 
and RBD, which is linked to neurological disease, often 
a neurodegenerative process. Instead, post-traumatic and 
current psychological stressors are typical of REM nightmare 
disorder and psychological stress is associated with NREM 
disorders (34,36,37). Emotionally loaded events, even 
positive ones, are commonly reported to precede NREM 
parasomnias, possibly explained by high arousal and sleep 
stage dissociation (39).  
Surprisingly, PSG and neurologically examined NREM 
parasomnia patients later reported frequent violent and 
injurious behaviour with simple dream enactment (55). 
Possible mechanisms presented were sleep stage dissociation 
and impaired inhibitory control of motor systems (39), further 
supporting the theory of symptoms evolving from NREM 
parasomnias towards POD with behavioural and PSG features 
of RBD, and POD being distinct from RBD (52). 
In PTSD, nightmare disorder is frequently reported (up to 
80% of patients), but this diagnosis does not acknowledge the 
presence of disruptive nocturnal dream enactment behaviour. 
However, disruptive nocturnal motor behaviour accompanied 
by autonomic hyperarousal, abnormal vocalizations and 
replay of traumatic experiences in nightmares are frequently 
reported in trauma survivors with and without PTSD. Even if 
secondary REM sleep behaviour disorder is reported in PTSD 
patients, with the lack of REM atonia in PSG accompanied 
with dream enactment behaviour, no accurate diagnosis to 
encompass the complex and disruptive motor behaviour in 
PTSD is available. For these patients, a new diagnostic entity 
is suggested as “Trauma associated sleep disorder”, TSD (55). 
Typical TSD dream content is different from RBD and 
POD. The nightmares of RBD tend to have quite similar 
themes of animals and self-defence against enemies, whereas 
the nightmares of TSD are unique to each patient with 
replay of traumatic experiences (55). The preliminary TSD 
treatment approache (IRT, prazosin) focuses on nightmares 
(55). Our patient, despite having PTSD, reported no recurrent, 
identifi ed nightmare narrative to offer focus for IRT and the 
replay of traumatic experiences was infrequent. Rather, the 
dream content showed features of vague NREM dreams and 
violent fi ghting themes typical of RBD.  
Traumatic nightmare enactment may share the same 
mechanism (sleep stage dissociation and impaired inhibitory 
control of motor systems) that is suggested to lie behind 
disruptive enactment of NREM dreams (39). However, there 
is no clear explanation for the dysregulation of REM sleep 
muscle tone in PTSD patients with nightmares. Simultaneous 
hyperarousal with defi cient fi ltering of stimuli, continuous 
alertness and hyper-reactivity to potentially “threatening” 
external cues, and consequent disruption of sleep with 
incomplete transitions between sleep and wake typical of 
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parasomnia, may contribute to increased sympathetic and 
muscle tone with consequent enactment of nightmares. Other 
possible explanations include incomplete transitions between 
NREM and REM sleep, as the disruption of REM sleep may 
lead to increased homeostatic sleep pressure for intrusions of 
REM sleep into NREM sleep. 
The patient himself was described to be continuously 
at “hyperarousal state” day and night. According to his 
girlfriend, he reacted to even the smallest outside stimuli with 
violent attacks during sleep. He recognized motor hyper-
reactivity, tension and restlessness both day and night. The 
“hyperarousal state” could be related to central sensitization, 
low parasympathetic tone and high sympathetic tone (56). 
In PTSD, sensitizing of the central nervous system’s arousal 
centres can lead to pronounced central and physiological 
hyperarousal (57). 
After treatment for POD, his sleep quality and daytime 
well-being were better, probably with bidirectional causality. 
He returned to his work after a long sick leave, showing the 
clinical importance of treating comorbid sleep disorders of 
patients with psychiatric disability. 
There is no established treatment for POD. Sustained 
release melatonin and benzodiazepines have been commonly 
used medications for patients with POD, and usually the 
response has been good. In some cases, the symptoms have 
resolved after discontinuation of provoking medications, 
such as antidepressants, antipsychotics or zolpidem (50,58). 
Behavioural and psychotherapeutic techniques aimed at 
lowering arousal, stabilizing sleep and coping with stress may 
be useful for POD. In this case, the treatment of secondary 
insomnia may have reinforced the initial positive response 
to doxepin by further stabilizing sleep and offering coping 
strategies for anxiety. Because of PTSD, the patient was 
also referred to psychotherapy, which probably advances 
the recovery from parasomnias by relieving anxiety and 
hyperarousal.
As far as we know, this is the first report of doxepin used 
successfully used in the treatment of parasomnia overlap 
disorder. In small doses, doxepin acts primarily as a histamine 
H1 receptor inverse agonist. With doses above 10mg it has an 
antimuscarinic action that reduces REM sleep, thus potentially 
lowering the occurrence of REM parasomnias. Low-dose 
doxepin is recommended by the AASM (59) and the Finnish 
Sleep Research Society (60) for treatment of insomnia 
disorder, and our patient was suffering from secondary 
insomnia. Based on this case, we are cautious in making 
conclusions about the mechanism of response. At least part of 
the positive response can be linked to the normalizing action 
of doxepin on both NREM sleep and REM sleep without 
affecting brain processing or emotional pathways to the same 
degree as, for example, benzodiazepines. 
Further trials are needed to establish effective and safe 
pharmacological treatment options and to standardize non-
pharmacological methods for complex parasomnias with 
overlapping clinical pictures. In psychiatric patients, the 
predisposing antidepressant and antipsychotic medications 
should be considered as a possible secondary aetiology for 
RBD symptoms. Antidepressants indicated for concomitant 
anxiety disorder, common in NREM parasomnias, can increase 
the muscle tonus during REM sleep, thus predisposing to 
POD (61).
The quality of sleep and sleep-related symptoms are of 
clinical importance for psychiatric assessment, addressed 
by differential diagnosis as focus of treatment, and noted 
as possible factors behind relapses, residual symptoms and 
treatment-resistant psychiatric disorders. As an example 
of diagnostically challenging, debilitating and injurious 
parasomnia symptoms with psychiatric comorbidity, we 
present a patient case. The clinical picture could not be 
classified clearly to either main parasomnia category (REM 
nor NREM parasomnia), but something between them, better 
described as a parasomnia overlap disorder.
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an example of diagnostically challenging, debilitating and injurious parasomnia symptoms 
with psychiatric comorbidity, we present a patient case. The clinical picture could not be 
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         Figure 5.  “With wings of dream” Ulla Santanen.  
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